Dr. Donglu Zhang
is a Principal Scientist at Bristol-Myers Squibb in Princeton, NJ. Dr. Zhang?s research interests include identification of metabolites and metabolism enzymes, investigation of metabolism-based toxicity, LC/MS methodologies, microbial biotransformation, and their applications to drug discovery and development. Dr. Zhang earned his Ph.D. from Dale Poulter?s labs in Bioorganic Chemistry from University of Utah. He has frequently taught short courses at ACS and EAS, is a co-editor of the book ?Drug metabolism in drug design and development?, a co-inventor of mass defect filtering technology, and has published >60 peer-reviewed articles.